Pharmaceutical Technology21h
Tevimbra by BeiGene for Gallbladder Cancer: Likelihood of Approval
Tevimbra is under clinical development by BeiGene and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success ...
Pharmaceutical Technology21h
Tevimbra by BeiGene for Muscle Invasive Bladder Cancer (MIBC): Likelihood of Approval
Tevimbra is under clinical development by BeiGene and currently in Phase II for Muscle Invasive Bladder Cancer (MIBC).